Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: The TPL Group Files Appeal to Reverse Markman Claim Construction for US ‘584 Patent in MMP™ Portfolio
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
The TPL Group Files Appeal to Reverse Markman Claim Construction for US ‘584 Patent in MMP™ Portfolio
posted on
Sep 27, 2007 12:34PM
September 27, 2007 04:30 PM
The TPL Group Files Appeal to Reverse Markman Claim Construction for US ‘584 Patent in MMP™ Portfolio
Strategic Appeal Expected to Reverse Single US ‘584 “Instruction Groups” Claim Construction in US Court of Appeals for the Federal Circuit